Oxybutynin Base en es it fr

Oxybutynin Base Brand names, Oxybutynin Base Analogs

Oxybutynin Base Brand Names Mixture

  • No information avaliable

Oxybutynin Base Chemical_Formula


Oxybutynin Base RX_link


Oxybutynin Base fda sheet

Oxybutynin_Base FDA

Oxybutynin Base msds (material safety sheet)

Oxybutynin_Base MSDS

Oxybutynin Base Synthesis Reference

Brit. pat. 940540 (1963 to Mead Johnson)

Oxybutynin Base Molecular Weight

357.486 g/mol

Oxybutynin Base Melting Point

129-130 oC

Oxybutynin Base H2O Solubility

No information avaliable

Oxybutynin Base State


Oxybutynin Base LogP


Oxybutynin Base Dosage Forms

Patch; Syrup; Tablet; Tablet (extended-release)

Oxybutynin Base Indication

For the treatment of overactive bladder.

Oxybutynin Base Pharmacology

Oxybutynin is an antispasmodic, anticholinergic agent indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Oxybutynin relaxes bladder smooth muscle. Oxybutynin exhibits only one-fifth of the anticholinergic activity of atropine on the rabbit detrusor muscle, but four to ten times the antispasmodic activity. Antimuscarinic activity resides predominantly in the R-isomer.

Oxybutynin Base Absorption

Rapidly absorbed from gastrointestinal tract.

Oxybutynin Base side effects and Toxicity

LD50=1220 mg/kg (Orally in rats, Goldenthal)

Oxybutynin Base Patient Information

Patient should be informed that oxybutynin may produce drowsiness or blurred vision. Alcohal may enhance the drowsiness caused by anticholinergic agents. Fever and heat stroke can occur while anticholinergics are administered in the presence of high environmental temparature. Medication should be taken with the aid of liquids at approximately the same time each day. Patients should not chew, divide, or crush tablets.

Oxybutynin Base Organisms Affected

Humans and other mammals